Plain-English translation of NCT05772559 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting bone marrow samples from children and young adults (up to age 25) who have acute myeloid leukemia (a serious blood cancer) at initial diagnosis or when it comes back. Researchers will study the genetic makeup of cancer cells and test how different drugs work against them in the laboratory. The goal is to better understand why some patients relapse and to eventually predict which patients are at highest risk.
Acute myeloid leukemia in young people has a poor outlook, with about 35–45% of patients experiencing relapse even after initial treatment. By analyzing the genetic changes in cancer cells and how they respond to different drugs in the lab, doctors hope to identify which patients need more aggressive treatment and develop better, more personalized approaches to prevent relapse.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a bone marrow sample collected as part of your regular medical care — this is often done anyway for diagnosis or monitoring. That sample will then be sent to researchers who will study the genetic changes in your cancer cells and test how different medications work against them in the laboratory. There is no additional treatment or medication involved; this is purely a research study to help doctors better understand your disease.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France